•  Home
  • Library
  • DRO home
Submit research Contact DRO

DRO

Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer

Kanwar, Rupinder K and Kanwar, Jagat R 2013, Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer, Protein & peptide letters, vol. 20, no. 4, pp. 450-458, doi: 10.2174/0929866511320040009.

Attached Files
Name Description MIMEType Size Downloads

Title Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer
Author(s) Kanwar, Rupinder K
Kanwar, Jagat RORCID iD for Kanwar, Jagat R orcid.org/0000-0003-3728-9568
Journal name Protein & peptide letters
Volume number 20
Issue number 4
Start page 450
End page 458
Total pages 9
Publisher Bentham Science Publishers
Place of publication Bussum, The Netherlands
Publication date 2013
ISSN 1875-5305
0929-8665
Keyword(s) anti-apoptotic proteins
immunomodulatory
angiogenesis
tumour growth
drug resistance
radioresistance
anti-inflammatory
Summary Lactoferrin (Lf), an iron binding ~80 kDa glycoprotein is a well characterized multifunctional protein found to be present in mammalian milk and in most exocrine secretions. Besides Lf’s important physiological roles in the process of iron homeostasis, iron transportation and sequestration, it is well known for its properties such as anti-microbial, antiviral anti-inflammatory and immunomodulatory functions. In the recent decade, Lf has gained significant attention for its future potential use as a safer natural food (bovine milk) derived anti-cancer therapeutic. With regards to Lf’s chemopreventive effects in targeting carcinogenesis, both animal and human studies have widely reported its immunomodulatory properties to play a significant role. The deregulation of apoptosis (programmed cell death) mechanisms has not only major implications for the development of uncontrolled tumour growth but evasion of apoptosis is also an important factor affecting drug resistance and radioresistance in cancer. With the exception of few studies, the molecular basis by Lf treatment remains unclear. In this review, by addressing the main features of Lf’s structure and function we discuss the recent developments in delineating the therapeutic mechanisms of Lf and its effects on the proteins and receptors modulating apoptosis.
Notes
ATTENTION ERA 2015 CLUSTER LEADERS: The Library does not currently have access to the research output associated with this record, please contact DRO staff for further information regarding access.drosupport@deakin.edu.au

Language eng
DOI 10.2174/0929866511320040009
Field of Research 060103 Cell Development, Proliferation and Death
Socio Economic Objective 970106 - Expanding Knowledge in the Biological Sciences, 970111 - Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Persistent URL http://hdl.handle.net/10536/DRO/DU:30054668

Document type: Journal Article
Collection: Faculty of Health
Related Links
Link Description
Connect to published version (restricted access)
Go to link with your DU access privileges
 
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 35 times in TR Web of Science
Scopus Citation Count Cited 35 times in Scopus Google Scholar Search Google Scholar
Access Statistics: 701 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Mon, 29 Jul 2013, 18:45:25 EST by Rupinder Kanwar

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.